CD34 and head and neck squamous cell carcinoma: Indeed, 25-hydroxyvitamin D3 reduced the circulating CD34+ MDSCs in HNSCC patients which resulted in increased levels of plasma IL-12 and IFN-γ and T cell proliferation [116].